This product is a recombinant human antibody that can recognize IAV HA. This antibody effectively reacting with all influenza A hemagglutinin (HA) subtypes. The antibody is the second cross-group neutralizing antibody for which structures of complexes with both group1 and group 2 HAs have been reported.
Figure 1 Recombinant Human Anti-IAV HA Antibody (PABC-393) in SDS-PAGE
SDS-PAGE analysis of PABC-393 in non-reduced (Lane 1) and reduced (Lane 2) conditions.
Figure 2 Recombinant Human Anti-IAV HA Antibody (PABC-393) in HPLC
HPLC analysis of PABC-393 shows the purity is>90%.
Figure 3 Human Anti-IAV HA Antibody (PABC-393) in WB 1
Western blot analysis was performed by loading Antigen Influenza A H3N2 (A/Perth/16/2009) Hemagglutinin / HA Protein (His Tag) onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least 1 hour. Membranes were probed with Anti-IAV HA Antibody (PABC-393) at a concentration of 1 μg/mL overnight at 4°C on a rocking platform. Then probed with Goat anti-Mouse IgG HRP secondary antibody at a dilution of 1:8,000 for one hour. Chemiluminescent was detected.
Lane 1: Reducing antigen (0.3 μg)
Lane 2: Reducing antigen (0.6 μg)
Figure 4 Human Anti-IAV HA Antibody (PABC-393) in WB 2
Western blot analysis was performed by loading Antigen Influenza A H3N2 (A/Victoria/210/2009) Hemagglutinin / HA Protein (His Tag) onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least 1 hour. Membranes were probed with Anti-IAV HA Antibody (PABC-393) at a concentration of 1 μg/mL overnight at 4°C on a rocking platform. Then probed with Goat anti-Mouse IgG HRP secondary antibody at a dilution of 1:8,000 for one hour. Chemiluminescent was detected.
Lane 1: Reducing antigen (0.3 μg)
Lane 2: Reducing antigen (0.6 μg)
Figure 5 Human Anti-IAV HA Antibody (PABC-393) in WB 3
Western blot analysis was performed by loading Antigen Influenza A H2N2 (A/Japan/305/1957) Hemagglutinin / HA Protein (His Tag) onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least 1 hour. Membranes were probed with Anti-IAV HA Antibody (PABC-393) at a concentration of 1 μg/mL overnight at 4°C on a rocking platform. Then probed with Goat anti-Mouse IgG HRP secondary antibody at a dilution of 1:8,000 for one hour. Chemiluminescent was detected.
Lane 1: Reducing antigen (0.3 μg)
Lane 2: Reducing antigen (0.6 μg)
Figure 6 Human Anti-IAV HA Antibody (PABC-393) in WB 4
Western blot analysis was performed by loading Antigen Influenza A [A/Hong Kong/483/97 (H5N1)] Hemagglutinin (HA) Protein, His Tag onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least 1 hour. Membranes were probed with Anti-IAV HA Antibody (PABC-393) at a concentration of 1 μg/mL overnight at 4°C on a rocking platform. Then probed with Goat anti-Mouse IgG HRP secondary antibody at a dilution of 1:8,000 for one hour. Chemiluminescent was detected.
Lane 1: Reducing antigen (0.3 μg)
Lane 2: Reducing antigen (0.6 μg)
Figure 7 Human Anti-IAV HA Antibody (PABC-393) in ELISA 1
ELISA analysis of PABC-393 was performed by coating with Antigen Influenza A H3N2 (A/Perth/16/2009) Hemagglutinin / HA Protein (His Tag). Then blocked with BSA and incubated with Anti-IAV HA Antibody (PABC-393) at a starting concentration of 2 ng/mL. The HRP-conjugated goat anti-Mouse IgG as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.
Figure 8 Human Anti-IAV HA Antibody (PABC-393) in ELISA 2
ELISA analysis of PABC-393 was performed by coating with Antigen Influenza A H3N2 (A/Victoria/210/2009) Hemagglutinin / HA Protein (His Tag). Then blocked with BSA and incubated with Anti-IAV HA Antibody (PABC-393) at a starting concentration of 2 ng/mL. The HRP-conjugated goat anti-Mouse IgG as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.
Figure 9 Human Anti-IAV HA Antibody (PABC-393) in ELISA 3
ELISA analysis of PABC-393 was performed by coating with Antigen Influenza A H2N2 (A/Japan/305/1957) Hemagglutinin / HA Protein (His Tag). Then blocked with BSA and incubated with Anti-IAV HA Antibody (PABC-393) at a starting concentration of 2 ng/mL. The HRP-conjugated goat anti-Mouse IgG as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.
Figure 10 Human Anti-IAV HA Antibody (PABC-393) in ELISA 4
ELISA analysis of PABC-393 was performed by coating with Antigen Influenza A [A/Hong Kong/483/97 (H5N1)] Hemagglutinin (HA) Protein, His Tag. Then blocked with BSA and incubated with Anti-IAV HA Antibody (PABC-393) at a starting concentration of 2 ng/mL. The HRP-conjugated goat anti-Mouse IgG as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.
Figure 11 Human Anti-IAV HA Antibody (PABC-393) in DB 1
Dot Blot analysis of PABC-393 was performed by coating with Antigen Influenza A H3N2 (A/Perth/16/2009) Hemagglutinin / HA Protein (His Tag).
PABC-393 incubation concentration: 2 ng/μL.
The secondary antibody: HRP-Goat Anti-Mouse IgG (H+L)
Figure 12 Human Anti-IAV HA Antibody (PABC-393) in DB 2
Dot Blot analysis of PABC-393 was performed by coating with Antigen Influenza A H3N2 (A/Victoria/210/2009) Hemagglutinin / HA Protein (His Tag).
PABC-393 incubation concentration: 2 ng/μL.
The secondary antibody: HRP-Goat Anti-Mouse IgG (H+L)
Figure 13 Human Anti-IAV HA Antibody (PABC-393) in DB 3
Dot Blot analysis of PABC-393 was performed by coating with Antigen Influenza A H2N2 (A/Japan/305/1957) Hemagglutinin / HA Protein (His Tag).
PABC-393 incubation concentration: 2 ng/μL.
The secondary antibody: HRP-Goat Anti-Mouse IgG (H+L)
Figure 14 Human Anti-IAV HA Antibody (PABC-393) in DB 4
Dot Blot analysis of PABC-393 was performed by coating with Antigen Influenza A [A/Hong Kong/483/97 (H5N1)] Hemagglutinin (HA) Protein, His Tag.
PABC-393 incubation concentration: 2 ng/μL.
The secondary antibody: HRP-Goat Anti-Mouse IgG (H+L)
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NABG-078 | Recombinant Anti-IAV HA VHH Single Domain Antibody | FC, CA, IP, FuncS | Llama VHH |
HPAB-0344CQ | Recombinant Llama Anti-IAV HA Single Domain Antibody (HPAB-0344CQ) | ELISA, Neut | Llama VHH |
HPAB-0345CQ | Recombinant Llama Anti-IAV HA Single Domain Antibody (HPAB-0345CQ) | ELISA, Neut | Llama VHH |
There are currently no Customer reviews or questions for PABC-393. Click the button above to contact us or submit your feedback about this product.
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# PABC-393, RRID: AB_3111586)
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.